Wells Fargo Upgrades Albemarle to Overweight, Raises Price Target to $285
Wells Fargo analyst Michael Sison upgrades Albemarle (NYSE:ALB) from Equal-Weight to Overweight and raises the price target from $215 to $285.
Keybanc Maintains Underweight on Albemarle, Raises Price Target to $215
Keybanc analyst Aleksey Yefremov maintains Albemarle (NYSE:ALB) with a Underweight and raises the price target from $198 to $215.
Mizuho Maintains Neutral on Albemarle, Raises Price Target to $293
Mizuho analyst Christopher Parkinson maintains Albemarle (NYSE:ALB) with a Neutral and raises the price target from $243 to $293.
83 Biggest Movers From Yesterday
Gainers
Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.
24 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Austin Gold (NYSE: AUST) shares rose 30.3% to $5.70 in pre-market trading after gaining around 9% on Wednesday. Austin Gold had its IPO on Wednesday at $5 per share.
Albemarle Shares Are Surging After Hours: Here’s Why
Albemarle Corp (NYSE: ALB) shares are trading higher in Wednesday's after-hours session after
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Looking At Albemarle’s Recent Whale Trades
A whale with a lot of money to spend has taken a noticeably bullish stance on Albemarle.
Looking at options history for Albemarle (NYSE:ALB) we detected 28 strange trades.
Why Now Is The Time To Watch These 8 Lithium Stocks
During the Tesla Inc (NASDAQ: TSLA) earnings call on Wednesday, CEO Elon Musk asked for more public investments in the lithium mining industry.